167. New Developments in Tuberculosis
Saturday, October 5, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 120-125
Co-organized with the Center for Global Health Policy

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • use new approaches to the diagnosis of tuberculosis in children
  • treat drug-susceptible and drug-resistant tuberculosis in children
  • describe the Roadmap for Childhood Tuberculosis

Target Audience: public health practitioners, pharmacists, nurses, microbiologists, members-in-training, medical students and residents, infectious diseases physicians, infectious diseases pediatricians, HIV specialists, HIV clinicians, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, HIV-STD-TB, Global ID, Adult ID

Moderator:  Ronald De Groot, MD, PhD, Radboud University

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-087-L01-P


R. De Groot, None

J. A. Seddon, None

J. Starke, None

D. Lewinsohn, VITi, Inc: Employee and I am president of Viti, My husband and I hold stock options and Salary

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.